Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/39083


Biopharmaceuticals - Current Market Dynamics and Future Outlook


Description: The biopharmaceutical market has come along way since 1982 when the first biopharmaceutical product, recombinant human insulin, was launched. Over 130 such products are currently being marketed around the world including thirteen blockbuster drugs.

The global market for biopharmaceuticals, which is currently valued at US$48 billion, has been growing at an impressive compound annual growth rate of 19% over the previous five years.

With over one third of all pipe-line products in active development are biopharmaceuticals, this segment is set to continue outperforming the total pharmaceutical market and could easily reach US$100 billion by the end of the decade.

This report reviews the current status of the market of biopharmaceuticals, highlights the differences between regional markets, maps leading biopharmaceutical classes and discusses the different windows of opportunities opening in this market including the potential for biogenerics.

The report provides figures of market size, growth rates and historical evolution of the global, North American, European and Japanese biopharmaceutical markets.

It also provides sales and growth rate figures for the following leading biopharmaceutical products with combined revenue of over US$38 billion: Epogen / Aranesp, Eprex / Procrit / Erypo, Remicade, Neupogen / Neulasta, MabThera / Rituxan, Avonex, Enbrel, Pegasys / Roferon A, Peg-Intron / Intron A, Betaferon / Betaseron, Humulin / Humalog, Rebif, Synagis and Herceptin.

Erythropoietins with a market size of over US$11 billion and rising, Monoclonal Antibodies with a market size approaching US$10.2 billion and a stratospheric growth rate, Human Insulin and analogs, Interferon and Colony Stimulating Factors are some of the main biopharmaceutical classes profiled in this report.

Each class profile contains a thoughtful market dynamics analysis including size, evolution, growth rate, leading participants’ market shares and highlights of the strategic opportunities relating to that particular segment of the market.

The report also discusses the biopharmaceutical market outlook, growth potential, attractive areas of growth, technological innovations, products in development and biogenerics opportunities.

Written with the senior executive needs in mind, Biopharmaceuticals – Current Market Dynamics & Future outlook, is a must read for pharmaceutical and medical biotech professionals interested in high growth area therapeutics.


Contents: 1. Executive Briefing

2. Introduction

2.1 Definition & Scope
2.2 Brief Chronology of Biotechnology in Human Health
2.3 Biopharmaceutical Categories
2.3.1 Hormones & Enzymes
2.3.2 Cytokines
2.3.3 Vaccines & Antigens
2.3.4 Monoclonal Antibodies
2.3.5 Antisense
2.3.6 Cell Therapy

3. Market Size & Growth Rates

3.1 Global Market for Biopharmaceuticals
3.2 North American Market for Biopharmaceuticals
3.3 European Market for Biopharmaceuticals
3.4 Japanese Market for Biopharmaceuticals
3.5 Factors Driving the Market

4. Leading Biopharmaceutical Brands

4.1 Epogen / Aranesp
4.2 Eprex / Procrit / Erypo
4.3 Remicade (infliximab)
4.4 Neupogen / Neulasta
4.5 Rituxan / MabThera
4.6 Humulin / Humalog
4.7 Enbrel
4.9 Avonex
4.10 Rebif
4.11 Pegasys / Roferon A
4.12 Herceptin (trastuzumab)
4.13 Betaferon / Betaseron
4.14 Peg-Intron / Intron A
4.15 Synagis (palivizumab)

5. Leading Biopharmaceutical Classes

5.1 Erythropoietin & Analogs
5.1.1 Overview
5.1.2 Market Revenue & Growth Rates
5.1.3 Leading Participants Market Shares
5.1.4 Strategic Opportunities

5.2 Monoclonal Antibodies
5.2.1 Overview
5.2.2 Market Revenue & Growth Rates
5.2.3 Leading Participants Market Shares
5.2.4 Strategic Opportunities

5.3 Insulin & Analogs
5.3.1 Overview
5.3.2 Market Revenue & Growth Rates
5.3.3 Leading Participants Market Shares
5.3.4 Strategic Opportunities

5.4 Interferons
5.4.1 Overview
5.4.2 Market Revenue & Growth Rates
5.4.3 Leading Participants Market Shares
5.4.4 Strategic Opportunities

5.5 Colony Stimulating Factors
5.5.1 Overview
5.5.2 Market Revenue & Growth Rates
5.5.3 Leading Participants Market Shares
5.5.4 Strategic Opportunities

6. Future Outlook

6.1 Market Potential
6.2 Attractive Areas of Growth
6.3 Biopharmaceuticals in Active Development
6.4 Biogenerics – Opportunities, Threats & Strategic Issues


List of Tables

1. Global Market for Biopharmaceuticals (2000 – 2004) Market Revenue & Growth Rates
2. North American Market for Biopharmaceuticals (2000 – 2004) Revenue & Growth Rates
3. European Market for Biopharmaceuticals (2000 – 2004) Revenue & Growth Rates
4. Japanese Market for Biopharmaceuticals (2000 – 2004) Revenue & Growth Rates
5. Global Market for Biopharmaceuticals (2005 – 2010) Revenue Forecasts
6. Leading Biopharmaceutical Products (2004) Market Revenue & Growth Rates
7. Leading Biopharmaceutical Classes (2004) Market Revenue & Growth Rates
8. Epogen / Aranesp (2000 – 2004) Combined Global Revenue & Growth Rates
9. Epogen (2000 – 2004) Global Revenue & Growth Rate
10. Aranesp (2001 – 2004) Global Revenue & Growth Rate
11. Aranesp (2004) Geographical Breakdown of Revenue
12. Eprex / Procrit / Erypo (2000 – 2004) Global Revenue & Growth Rates
13. Remicade (infliximab) (2000 – 2004) Global Revenue & Growth Rates
14. Remicade (infliximab) (2000 – 2004) North American Revenue & Growth Rates
15. Neupogen / Neulasta (2000 – 2004) Combined Global Revenue & Growth Rates
16. Neupogen (2000 – 2004) Global Revenue & Growth Rates
17. Neupogen (2002 - 2004) Geographical Breakdown of Market Revenue
18. Neulasta (2001 – 2004) Global Revenue & Growth Rates
19. Neulasta (2002 - 2004) Geographical Breakdown of Market Revenue
20. Rituxan / MabThera (2000 – 2004) Combined Global Revenue & Growth Rates
21. Rituxan (2000 – 2004) North American Revenue & Growth Rates
22. Humulin / Humalog (2000 – 2004) Combined Global Revenue & Growth Rates
23. Humulin / Humalog (2000 – 2004) Geographical Breakdown of Market Revenue
24. Enbrel (2002 – 2004) Global Revenue & Growth Rates
25. Enbrel (2002 – 2004) Geographical Breakdown of Market Revenue
26. NeoRecormon / Epogin (2000 – 2004) Combined Global Revenue & Growth Rates
27. NeoRecormon (2000 – 2004) Combined Market Revenue & Growth Rates
28. Epogin (2000 – 2004) Market Global Revenue & Growth Rates
29. Avonex (2000 – 2004) Global Revenue & Growth Rates
30. Rebif (2000 – 2004) Global Revenue & Growth Rates
31. Pegasys / Roferon A (2000 – 2004) Combined Market Revenue & Growth Rates
32. Pegasys (2000 – 2004) Market Revenue & Growth Rates
33. Roferon A (2000 – 2004) Global Revenue & Growth Rates
34. Peg-Intron / Intron A (2000 – 2004) Combined Market Revenue & Growth Rates
35. Peg-Intron (2000 – 2004) Market Revenue & Growth Rates
36. Intron A (2000 – 2004) Market Revenue & Growth Rates
37. Herceptin (2000 – 2004) Combined Global Revenue & Growth Rates
38. Herceptin (2000 – 2004) North American Revenue & Growth Rates
39. Betaseron / Betaferon (2000 – 2004) Global Revenue & Growth Rates
40. Synagis (2000 – 2004) Global Revenue & Growth Rates
41. Synagis (2000 – 2004) North American Revenue & Growth Rates
42. Erythropoietins (2000 – 2004) Global Revenue & Growth Rates
43. Erythropoietins (2004) Leading Companies Market Shares
44. Erythropoietins (2004) Leading Brands Market Shares
45. Epoetin Alfa – Key Patents Expiry Dates
46. Monoclonal Antibodies (2000 – 2004) Global Revenue & Growth Rates
47. Monoclonal Antibodies (2004) Leading Brands Market Shares
48. Insulins (2000 – 2004) Global Revenue & Growth Rates
49. Insulins (2004) Leading Companies Market Shares
50. Interferons (2000 – 2004) Global Revenue & Growth Rates
51. Market Segmentation by Interferon Type (2004)
52. Iterferons (2004) Leading Companies Market Shares
53. Colony Stimulating Factors (2000 – 2004) Global Revenue & Growth Rates
54. Colony Stimulating Factors (2004) Leading Brands Market Shares




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/39083

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 29/11/2009 09:41:58
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Biopharmaceuticals - Current Market Dynamics and Future Outlook
Web Address:
http://www.researchandmarkets.com/reports/39083
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic €835.00
Electronic - Site License €1,669.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 29/11/2009 09:41:58

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)